I have to admit a small fascination for tabloid, wildly over the top stories about stem cells. Maybe it’s just that I need a good laugh to escape the black hole of academia at times even if only momentarily? Of course some crazy stem cell stories reflect actually dangerous situations for patients, but that doesn’t […]
TGIF: Craziest stem cell stories of the week Read More »
How could there be a nose on top of head? We all have heard the expression “eyes on the back of one’s head”, but a nose on top of one’s head? What the heck? A Chinese doctor has apparently grown a new nose on top of a patient’s forehead. The patient had his nose damaged
Doc grows new nose on top of head Read More »
Late in 2012 I did a piece on the global trends in stem cell clinical trial patterns. It is time for an update. Another look at stem cell clinical trials now (late Sept. 2013) based on the clinicaltrials.gov database shows an encouraging trend. Total Stem Cell Clinical Trials The total number of stem cell clinical
Maps of global stem cell clinical trial trends Read More »
Guest post on talk by Jamie Thomson. By Jeanne Loring. On Wednesday afternoon at the ISSCR meeting in Boston, Jamie Thomson gave a talk about the history of human pluripotent stem cells. There were probably only a dozen people in the audience of around 3,000 who were working on human ES cells around the same
Jeanne Loring’s Thoughts on Jamie Thomson ISSCR Talk Read More »
One of the more exciting stem cell biotechs out there today is Advanced Cell Technology (ACT). At this time ACT has the only two ES cell-based FDA-approved clinical trials ongoing and so far they have looked quite promising in terms of preliminary safety data. However, ACT has much more in the pipeline including potentially iPS
Interview with Gary Rabin of Advanced Cell Technology (ACT) Read More »
A big issue in the stem cell field is that firms increasingly are doing business in multiple countries. Associated with the increasingly international nature of the stem cell for-profit industry are emerging legal and ethical issues related to the transport of stem cell-based biological drugs across international borders. Think you can just FedEx human stem
2012 Brazilian Congress on Stem Cells & Cell Therapy, Sao Paulo, Oct 3-6 NYSCF Seventh Annual Translational Stem Cell Research Conference, New York City Oct. 10 – 11 Epigenetics and Stem Cells 2012, Cambridge, UK Oct. 16 – 17, 2012 Texas Cures/ Texans for Stem Cell Research Education Mtg, Austin, Oct. 19 ISSCR-Roddenberry Symposium, Gladstone (San Fran), Oct. 24-25 Houston
2012 stem cell meetings and conferences Read More »
RNL Bio has been accused of allegedly smuggling stem cells out of Korea to treat patients in Japan and China without going through customs. But there is more trouble. RNL Bio faces additional challenges as reportedly (AsiaOne News) the Korean Government is weighing whether to charge RNL criminally based on their stem cell treatments being illegal
RNL Bio had a challenging year in 2012 in my opinion. It was sued in U.S. court for stem cell fraud by Korean national patients living in the U.S. It had a legal tussle, still ongoing, with former partner Celltex over custody of Celltex’s banked patient stem cells. Well, it seems to me that 2013
RNL Bio charges for alleged stem cell smuggling raise larger questions Read More »
Every now and then a paper on stem cells lands many international headlines and also captures people’s imaginations. This seems to be the case for the recent urine stem cell paper from a team in China, which has made huge headlines. In addition to mainstream media, the paper was covered in Wired here and also by one
Why did urine stem cell paper create global media sensation? Read More »